Part:BBa_K1041000:Experience

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Team NRP-UEA_Norwich 2013

Team NRP-UEA_Norwich 2013 added an NdeI restriction site at the start of the RFP coding region of BBa_J04450 using mutagenesis. This was to allow either the promoter region or RFP gene to be excised and exchanged for a different promoter or gene and provide restriction sites for further cloning such as part Bba_K1041002.

Characterisation of this biobrick involved comparisons with the original Bba_J04450 biobrick by performing transformations, restriction digests and BLAST analysis. We also had our biobrick sequenced.

Transformation

Parts BBa_K1041000 and BBa_J04450 were transformed into Alpha-Select competent E.Coli cells and plated onto LB Agar plates which contained the antibiotic ampicillin. Both plates have colonies that appear red under natural light fig.1. Therefore the addition of a NdeI site has not effected the ability for the RFP gene to be transcribed.

Fig 1: Plates containing (left) BBa_K1041000 and (right) BBa_J04450 visualized under non-UV lightbox

Sequencing

The biobrick was sent off to a company for sequencing, Fig 2,3,4.The data we recieved back showed the DNA is of good quality.

Fig. 2:K1041000 sequencing data part 1

Fig. 3:K1041000 sequencing data part 2

Fig. 4:K1041000 sequencing data part 3

BLAST Analysis

The data we recieved back from the sequencing company was aligned using BLAST with the expected DNA sequence Fig 5,6

Fig. 5: Forward primer K1041000 sequencing data aligned with the expected DNA sequence

Fig. 6: Reverse primer K1041000 sequencing data aligned with expected DNA sequence

User Reviews

UNIQ85eae9a0db50bc3f-partinfo-00000000-QINU UNIQ85eae9a0db50bc3f-partinfo-00000001-QINU